Skip to main content
WHITE PAPER
Weighing the
pros and cons
of GLP-1s

What to consider for better GLP-1 ROI for weight loss and outcomes that last

In recent years, glucagon-like peptide-1 receptor agonists (GLP-1s) have skyrocketed in popularity. Their effectiveness in promoting weight loss and improving metabolic health is now  well established, and researchers are exploring their potential use for a variety of conditions, ranging from dementia to addiction. 

However, as effective as they are in treating weight loss, they are not without drawbacks, such as high abandonment rates, substantial weight regain after treatment cessation, and costs of $1,000 or more per month.

Download our white paper to explore the benefits and limitations of  GLP-1 treatments for weight loss, and why they should be viewed as just one part of a holistic approach to health and wellness.

Download the white paper

Want to learn more?